Hospital News and Research

RSS

Researchers identify how sooty mangabeys survive SIV infection

Sooty mangabeys, a type of African monkey, have intrigued scientists for years because they can survive infection by SIV, a relative of HIV, and not succumb to AIDS.

27 Jun 2011

State roundup: Indiana's effort to privatize public assistance

(Louise) Cohoon's mother, now suffering from Alzheimer's disease, was one of thousands of Indiana residents who abruptly and erroneously lost their welfare, Medicaid or food stamp benefits after Republican Gov. Mitch Daniels privatized the state's public assistance program — the result of an efficiency plan that went awry from the very beginning, the state now admits.

27 Jun 2011

Teva concludes Site Initiation Visit for Israeli clinical center in CEL-SCI's Multikine Phase III clinical trial

CEL-SCI Corporation announced today that its partner Teva Pharmaceuticals, a leading global pharmaceutical company, has concluded the Site Initiation Visit for the first Israeli clinical center in CEL-SCI's Phase III clinical trial for Multikine, the Company's flagship cancer immunotherapy.

27 Jun 2011

Teleflex, Premier sign new three-year agreement for laryngoscopes

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced a new three-year agreement with Premier Purchasing Partners, L.P., the group purchasing unit of the Premier healthcare alliance.

27 Jun 2011

Health Canada approves Tasigna for newly diagnosed Philadelphia chromosome-positive CML

Over a decade ago, Canadian patients diagnosed with chronic myeloid leukemia (CML), celebrated when PrGleevec (imatinib mesylate) was approved in Canada.

27 Jun 2011

Spectranetics initiates enrollment in EXCITE clinical trial against femoropopliteal IRS

Spectranetics Corporation today announces the first patient enrollment in the EXCITE ISR (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis) clinical trial.

27 Jun 2011

New guide indicates when and how genetic testing is useful for inherited cardiac conditions

While genetic inheritance is known to play a role in the multifactorial development of most diseases of the heart, there are also a number of clearly diagnosed cardiac conditions which owe their development to quite specific genetic abnormalities. When these genetic disorders affect the integrity of the heart's muscle they are known as a "cardiomyopathy"; when the disorder affects the heart's "excitability", it is known as a "channelopathy".

27 Jun 2011

SOGC launches first Facebook game about healthy sexuality for Canadians

Today, the Society of Obstetricians and Gynaecologists of Canada is launching its first Facebook game - Sex Quest - to help Canadians learn about healthy sexuality, contraception and STIs.

27 Jun 2011

In vivo genome editing restores hemostasis in mouse model of blood clotting disorder

Using an innovative gene therapy technique called genome editing that hones in on the precise location of mutated DNA, scientists have treated the blood clotting disorder hemophilia in mice.

27 Jun 2011

Positive preliminary findings from ATI's neurostimulation system study on cluster headache

Autonomic Technologies, Inc. (ATI), the developer of a novel miniaturized implantable system for severe headaches, today announced positive preliminary findings from a study evaluating the safety and efficacy of the company's investigational neurostimulation system for the treatment of cluster headache.

27 Jun 2011

New anti-inflammatory drug improves kidney function in patients with type 2 diabetes

A new anti-inflammatory drug used by patients with type 2 diabetes improved their kidney function during a year-long study involving researchers from UT Southwestern Medical Center.

27 Jun 2011

Mortality, morbidity rates linked with AF remain 'unacceptably high' despite new treatments

Despite recent advances in the treatment of heart rhythm disturbances, mortality and morbidity rates associated with atrial fibrillation (AF) remain "unacceptably high", according to a new report.

27 Jun 2011

UVA to study how the 'Call to Health' model helps African-American women manage diabetes

The University of Virginia Health System has received a $300,000 grant to study the "Call to Health" model, which uses text messages, stress reduction and other techniques to help African-American women manage type 2 diabetes.

27 Jun 2011

Promising results from MGH's BCG Phase I trial on type I diabetes

Promising results of the Phase I clinical trial of the generic drug BCG to treat advanced type I diabetes were announced today at the American Diabetes Association scientific sessions in San Diego.

27 Jun 2011

Young adults with juvenile diabetes may face risk of heart attack and stroke

New research shows that adolescents and young adults with type 1 (juvenile) diabetes have thicker and stiffer carotid arteries, also known as atherosclerosis, a risk factor for heart attack and stroke in adults.

27 Jun 2011

Cardiac arrest represents tremendous problem for hospitals in the U.S.

More than 200,000 people are treated for cardiac arrest in United States hospitals each year, a rate that may be on the rise. The findings are reported online this week in Critical Care Medicine in a University of Pennsylvania Perelman School of Medicine-led study.

27 Jun 2011

Lilly, Harbour Antibodies complete non-exclusive research and licence deal

Harbour Antibodies BV, an Erasmus MC spin-off company, announced today the completion of a non-exclusive research and licence agreement with Eli Lilly and Company, a global pharmaceutical company, to generate and develop human therapeutic antibodies comprising immunoglobulin heavy and light chains(H2L2) using one of Harbour's transgenic mouse antibody discovery platforms.

27 Jun 2011

Diabetic patients can benefit from basal insulin analogs

Basal insulin analogs have revolutionized diabetes care, and especially the treatment of type 2 diabetes, enabling patients to achieve better control of blood glucose levels while reducing hypoglycemic episodes.

27 Jun 2011

New drug improves kidney function for patients with type 2 diabetes and chronic kidney disease

A new anti-inflammatory drug used by patients with type 2 diabetes improved their kidney function during a year-long study involving researchers from UT Southwestern Medical Center.

24 Jun 2011

Research roundup: Revamping public health law; Pay-for-performance

New Cardiac Surgery Programs Established From 1993 To 2004 Led To Little Increased Access, Substantial Duplication Of Services -- This study, using Medicare data from 1993-2004, finds that although the number of coronary artery bypass surgeries declined, 301 new cardiac surgery units opened.

24 Jun 2011

Hospital News and Research

Researchers identify how sooty mangabeys survive SIV infection

State roundup: Indiana's effort to privatize public assistance

Teva concludes Site Initiation Visit for Israeli clinical center in CEL-SCI's Multikine Phase III clinical trial

Teleflex, Premier sign new three-year agreement for laryngoscopes

Health Canada approves Tasigna for newly diagnosed Philadelphia chromosome-positive CML

Spectranetics initiates enrollment in EXCITE clinical trial against femoropopliteal IRS

New guide indicates when and how genetic testing is useful for inherited cardiac conditions

SOGC launches first Facebook game about healthy sexuality for Canadians

In vivo genome editing restores hemostasis in mouse model of blood clotting disorder

Positive preliminary findings from ATI's neurostimulation system study on cluster headache

New anti-inflammatory drug improves kidney function in patients with type 2 diabetes

Mortality, morbidity rates linked with AF remain 'unacceptably high' despite new treatments

UVA to study how the 'Call to Health' model helps African-American women manage diabetes

Promising results from MGH's BCG Phase I trial on type I diabetes

Young adults with juvenile diabetes may face risk of heart attack and stroke

Cardiac arrest represents tremendous problem for hospitals in the U.S.

Lilly, Harbour Antibodies complete non-exclusive research and licence deal

Diabetic patients can benefit from basal insulin analogs

New drug improves kidney function for patients with type 2 diabetes and chronic kidney disease

Research roundup: Revamping public health law; Pay-for-performance

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Latest News